Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2018 Feb 24;7(5):e007876.
doi: 10.1161/JAHA.117.007876.

High-Sensitivity Troponin T and C-Reactive Protein Have Different Prognostic Values in Hemo- and Peritoneal Dialysis Populations: A Cohort Study

Affiliations
Observational Study

High-Sensitivity Troponin T and C-Reactive Protein Have Different Prognostic Values in Hemo- and Peritoneal Dialysis Populations: A Cohort Study

Titi Chen et al. J Am Heart Assoc. .

Abstract

Background: Dialysis patients have an exceedingly high mortality rate. Biomarkers may be useful tools in risk stratification of this population. We evaluated the prognostic value of high-sensitivity cardiac troponin T (hs-cTnT) and CRP (C-reactive protein) in predicting adverse outcomes in stable hemodialysis and peritoneal dialysis (PD) patients. Variability in hs-cTnT was also examined.

Methods and results: A retrospective cohort study included 574 dialysis patients (hemodialysis 347, PD 227). Outcomes examined included mortality and major adverse cardiovascular events, with median follow-up of 3.5 years. hs-cTnT was an independent predictor of both outcomes in hemodialysis and PD patients. Increased risk only became significant when hs-cTnT reached quintile 3 (>49 ng/L). Area under the receiver operating curve analysis showed that the addition of hs-cTnT to clinical parameters significantly improved its prognostic performance for mortality in PD patients (P=0.002). CRP was an independent predictor of both outcomes in PD patients only. Only CRP in the highest quintile (>16.8 mg/L) was associated with increased risk. hs-cTnT remained relatively stable for the whole follow-up period for hemodialysis patients, whereas for PD patients, hs-cTnT increased by 23.63% in year 2 and 29.13% in year 3 compared with baseline (P<0.001).

Conclusions: hs-cTnT and CRP are useful tools in predicting mortality and major adverse cardiovascular events in hemodialysis and PD patients. Given that hs-cTnT levels increase over time in PD patients, interval monitoring may be valuable for risk assessment. In contrast, hs-cTnT in hemodialysis patients has little interval change and progress monitoring is not indicated.

Keywords: biomarker; end‐stage renal disease; major adverse cardiac event; mortality; risk stratification.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Flow diagram for patients included in the study. HD indicates hemodialysis; PD, peritoneal dialysis.
Figure 2
Figure 2
Kaplan–Meier curves based on quintiles of hs‐cTnT for mortality (A and B) and MACE (C and D). HD indicates hemodialysis; hs‐cTnT, high‐sensitivity cardiac troponin T; MACE, major adverse cardiovascular events; PD, peritoneal dialysis; Q, troponin quintile.

Similar articles

Cited by

References

    1. ANZDATA Registry . 38th report, Chapter 3: mortality in end stage kidney disease [Internet]. Australia and New Zealand Dialysis and Transplant Registry. 2016. Available at: http://www.anzdata.org.au/anzdata/AnzdataReport/38thReport/c03_anzdata_d.... Accessed December 15, 2016.
    1. Herzog CA, Asinger RW, Berger AK, Charytan DM, Diez J, Hart RG, Eckardt KU, Kasiske BL, McCullough PA, Passman RS, DeLoach SS, Pun PH, Ritz E. Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 2011;80:572–586. - PubMed
    1. Akchurin OM, Kaskel F. Update on inflammation in chronic kidney disease. Blood Purif. 2015;39:84–92. - PubMed
    1. Michos ED, Wilson LM, Yeh HC, Berger Z, Suarez‐Cuervo C, Stacy SR, Bass EB. Prognostic value of cardiac troponin in patients with chronic kidney disease without suspected acute coronary syndrome: a systematic review and meta‐analysis. Ann Intern Med. 2014;161:491–501. - PubMed
    1. Khan NA, Hemmelgarn BR, Tonelli M, Thompson CR, Levin A. Prognostic value of troponin T and I among asymptomatic patients with end‐stage renal disease: a meta‐analysis. Circulation. 2005;112:3088–3096. - PubMed

Publication types

MeSH terms